INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 188 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,130 | -9.0% | 501,625 | +10.6% | 0.41% | -1.2% |
| Q2 2023 | $28,708 | +3.7% | 453,375 | -11.3% | 0.41% | +2.0% |
| Q1 2023 | $27,675 | -26.1% | 511,075 | -27.8% | 0.40% | -24.2% |
| Q4 2022 | $37,467 | -99.9% | 708,000 | -20.0% | 0.53% | -7.0% |
| Q3 2022 | $41,203,000 | -9.9% | 885,510 | +10.6% | 0.57% | -10.0% |
| Q2 2022 | $45,712,000 | -14.8% | 800,838 | -8.7% | 0.64% | +5.8% |
| Q1 2022 | $53,665,000 | -23.7% | 877,028 | -34.7% | 0.60% | -3.4% |
| Q4 2021 | $70,343,000 | +9.8% | 1,343,965 | -21.8% | 0.62% | +11.4% |
| Q3 2021 | $64,072,000 | +36.1% | 1,718,665 | +49.0% | 0.56% | +45.2% |
| Q2 2021 | $47,081,000 | +13.1% | 1,153,380 | -6.0% | 0.38% | +7.8% |
| Q1 2021 | $41,642,000 | +47.3% | 1,227,280 | +38.0% | 0.36% | +55.2% |
| Q4 2020 | $28,277,000 | +22.1% | 889,200 | -1.5% | 0.23% | +6.0% |
| Q3 2020 | $23,158,000 | -0.0% | 902,500 | -41.2% | 0.22% | +40.0% |
| Q4 2016 | $23,162,000 | -13.5% | 1,534,938 | -12.6% | 0.16% | -10.4% |
| Q3 2016 | $26,770,000 | -57.4% | 1,756,575 | +8.4% | 0.17% | -58.4% |
| Q2 2016 | $62,884,000 | +48.4% | 1,619,875 | +6.3% | 0.42% | +50.2% |
| Q1 2016 | $42,378,000 | -40.2% | 1,524,375 | +15.6% | 0.28% | -38.0% |
| Q4 2015 | $70,918,000 | +61.0% | 1,318,420 | +19.9% | 0.45% | +62.0% |
| Q3 2015 | $44,044,000 | – | 1,100,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |